Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Living Cell Technologies ( (AU:1AI) ) has issued an update.
Algorae Pharmaceuticals Limited has announced the issuance of 42,000,000 unquoted employee performance rights as part of a previously announced transaction. This issuance is not intended to be quoted on the ASX, and it reflects the company’s ongoing efforts to incentivize and retain its workforce, potentially impacting its operational efficiency and market competitiveness.
More about Living Cell Technologies
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$10.12M
Find detailed analytics on 1AI stock on TipRanks’ Stock Analysis page.